Dr. Shahid Mudasir Ahmad Baba

Assistant Professor

Curriculum Vitae

Contact Info

  • shahid.mudasir@iust.ac.in
  • 7006694465

Research Links

Overview

30

Publications

5

Conferences

1

Books

2

Book Chapters

0

Projects

2

FDP/ Workshops

0

Scholars

0

Patents

Overview

30

Total Publications

AuthorTypeTotal
First Author12
Co-Author18
IndexingTotal
UGC-CARE List Group II (Scopus Only)1
UGC-CARE List Group II (Both Scopus and Web of Science)25
UGC-CARE List Group I1
Other3

Publication Details

 
1. Molecular investigation of vitamin D receptor (VDR) genetic variants and their impact on VDR mRNA and serum vitamin D levels in allergic rhinitis in an Indian population: A case–control study
Acceptance Date 23-03-2024
Publication Date Online 29-05-2024
Publication Date 05-10-2024
DOI https://doi.org/10.1111/iji.12679
Number of Authors 6
ISSN 1744-3121
EISSN 1744-313X
Journal International Journal of Immunogenetics
Listed In Thomson True
Impact Factor 2.3
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 51
Issue Number 5
Web Link https://pubmed.ncbi.nlm.nih.gov/38809236/
Web Link Journal https://onlinelibrary.wiley.com/journal/1744313x
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Islamic University of Science & Technology, Awantipora, Pulwama
2. Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL)
Acceptance Date 04-04-2024
Publication Date Online 08-04-2024
Publication Date 08-04-2024
DOI https://doi.org/10.1007/s12672-024-00971-9
Number of Authors 11
ISSN 2730-6011
EISSN 2730-6011
Journal Discover Oncology
Listed In Thomson True
Impact Factor 2.8
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 15
Issue Number 1
Web Link https://link.springer.com/article/10.1007/s12672-024-00971-9
Web Link Journal https://link.springer.com/article/10.1007/s12672-024-00971-9
Proof
Author Type Co-Author
Author Serial 8
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
3. Outcome of extra mucosal single interrupted layer (EMSIL) ileo-ileal anastomosis in urinary diversions during open radical cystectomy
Acceptance Date 20-04-2023
Publication Date Online 08-05-2023
Publication Date 01-12-2023
DOI doi: 10.1186/s12301-023-00357-3
Number of Authors 6
ISSN NA
EISSN 1961-9987
Journal AFRICAN JOURNAL OF UROLOGY
Listed In Thomson True
Impact Factor 0.38
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 29
Issue Number 1
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165284/
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165284/
Proof
Author Type Co-Author
Author Serial 4
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
4. Regulatory role of miR‐125a expression with respect to its target genes LIFR, ERBB2 and STAT3 in the pathogenesis of recurrent pregnancy losses
Acceptance Date 25-03-2024
Publication Date Online 25-03-2024
Publication Date 19-09-2023
DOI https://doi.org/10.1002/ijgo.15496
Number of Authors 13
ISSN 0020-7292
EISSN 1879-3479
Journal INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Listed In Thomson True
Impact Factor 3.2
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 166
Issue Number 3
Web Link https://pubmed.ncbi.nlm.nih.gov/38528801/#:~:text=Conclusion%3A%20The%20overall%20conclusion%20of,in%20the%20outcome%20of%20pregnancy.
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/38528801/#:~:text=Conclusion%3A%20The%20overall%20conclusion%20of,in%20the%20outcome%20of%20pregnancy.
Proof
Author Type Co-Author
Author Serial 5
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
5. Differential expression of SLITRK6 gene as a potential therapeutic target for urothelial carcinoma in particular upper tract cancer
Acceptance Date 01-07-2023
Publication Date Online 20-08-2023
Publication Date 20-08-2023
DOI https://doi.org/10.1016/j.gene.2023.147583
Number of Authors 14
ISSN 0378-1119
EISSN 1879-0038
Journal Gene
Listed In Thomson True
Impact Factor 3.5
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 878
Issue Number 0
Web Link https://www.sciencedirect.com/science/article/abs/pii/S0378111923004249
Web Link Journal https://www.sciencedirect.com/science/article/abs/pii/S0378111923004249
Proof
Author Type Co-Author
Author Serial 4
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
6. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy
Acceptance Date 07-08-2023
Publication Date Online 10-08-2023
Publication Date 10-08-2023
DOI doi: 10.1016/j.cancergen.2023.08.005
Number of Authors 11
ISSN 2210-7762
EISSN 1873-4456
Journal Cancer Genetics
Listed In Thomson True
Impact Factor 1.9
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 278
Issue Number 0
Web Link https://pubmed.ncbi.nlm.nih.gov/37625215/#:~:text=Results%3A%20Of%20the%2039%20glioma,%2F19q%20co%2Ddeletions%20respectively.
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/37625215/#:~:text=Results%3A%20Of%20the%2039%20glioma,%2F19q%20co%2Ddeletions%20respectively.
Proof
Author Type Co-Author
Author Serial 8
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
7. Molecular typing of HLA-class II alleles reveals an association with autoantibodies and disease subsets of systemic sclerosis in a North Indian (Kashmir) population
Acceptance Date 30-04-2023
Publication Date Online 11-05-2023
Publication Date 01-06-2023
DOI https://doi.org/10.1016/j.ejr.2023.04.007
Number of Authors 10
ISSN 1110-1164
EISSN 2090-2433
Journal The Egyptian Rheumatologist
Listed In Thomson True
Impact Factor 0.9
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Scopus Only)
Volume Number 45
Issue Number 3
Web Link https://pdf.sciencedirectassets.com/280305/1-s2.0-S1110116423X00027/1-s2.0-S111011642300039X/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjENf%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJIMEYCIQDUQsjxRapo14zU0aboZHFnTOlhM7%2F6DEdF9qgyO%2BZ7RQIhAK0va4MzNtxL6hsomR%2F7MCGrU25NyCSmtsCsNJgWUAlVKrIFCF8QBRoMMDU5MDAzNTQ2ODY1IgzA6sgm3ogBeSABm5MqjwXRZofSBqBax1MPwiMu%2BE3c737OER6WHT9EDZHIHPEw%2FwJMWO%2Bn9ol1F0MJocr3MlXaUOzD4x%2FiL1HknmozDcbWBVJll7cIHjq0xgWTqmzrEqKYGhZDDS7UvjzJJ9whBhoqTPN5Lbwad409iNbREcV
Web Link Journal https://pdf.sciencedirectassets.com/280305/1-s2.0-S1110116423X00027/1-s2.0-S111011642300039X/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjENf%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJIMEYCIQDUQsjxRapo14zU0aboZHFnTOlhM7%2F6DEdF9qgyO%2BZ7RQIhAK0va4MzNtxL6hsomR%2F7MCGrU25NyCSmtsCsNJgWUAlVKrIFCF8QBRoMMDU5MDAzNTQ2ODY1IgzA6sgm3ogBeSABm5MqjwXRZofSBqBax1MPwiMu%2BE3c737OER6WHT9EDZHIHPEw%2FwJMWO%2Bn9ol1F0MJocr3MlXaUOzD4x%2FiL1HknmozDcbWBVJll7cIHjq0xgWTqmzrEqKYGhZDDS7UvjzJJ9whBhoqTPN5Lbwad409iNbREcV
Proof
Author Type Co-Author
Author Serial 8
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
8. Unveiling the TGF- β1 paradox: Significant implication of TGF- β1 promoter variants and its mRNA and protein expression in atopic dermatitis
Acceptance Date 01-04-2023
Publication Date Online 01-05-2023
Publication Date 01-05-2023
DOI doi: 10.1016/j.molimm.2023.04.006.
Number of Authors 10
ISSN 0161-5890
EISSN 1872-9142
Journal Molecular Immunology
Listed In Thomson True
Impact Factor 3.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 157
Issue Number 0
Web Link https://pubmed.ncbi.nlm.nih.gov/37084506/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/37084506/
Proof
Author Type Co-Author
Author Serial 8
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
9. Implications of risk conferred by 5p15.33 loci genetic variants; human telomerase reverse transcriptase rs2736098 and rs2736100 in predisposition of bladder cancer
Acceptance Date 06-07-2022
Publication Date Online 31-10-2022
Publication Date 31-10-2022
DOI doi: 10.5603/RPOR.a2022.0082
Number of Authors 11
ISSN 1507–1367
EISSN 2083–4640
Journal REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
Listed In Thomson True
Impact Factor 0.37
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 27
Issue Number 5
Web Link https://pubmed.ncbi.nlm.nih.gov/36523804/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/36523804/
Proof
Author Type Co-Author
Author Serial 6
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
10. GSTT1 null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients
Acceptance Date 13-09-2021
Publication Date Online 14-10-2021
Publication Date 14-10-2021
DOI doi: 10.3389/fonc.2021.714421
Number of Authors 10
ISSN 2234-943X
EISSN 2234-943X
Journal Frontiers in Oncology
Listed In Thomson True
Impact Factor 6.0
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 11
Issue Number 0
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552530/pdf/fonc-11-714421.pdf
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552530/pdf/fonc-11-714421.pdf
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
11. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir
Acceptance Date 06-09-2021
Publication Date Online 13-10-2021
Publication Date 13-10-2021
DOI doi: 10.3389/fimmu.2021.723814
Number of Authors 7
ISSN 1664-3224
EISSN 1664-3224
Journal Frontiers in Immunology
Listed In Thomson True
Impact Factor 8.9
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 12
Issue Number 0
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548833/pdf/fimmu-12-723814.pdf
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548833/pdf/fimmu-12-723814.pdf
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
12. Glutathione S-transferase gene polymorphic sequence variations: Association with risk and response to Imatinib among Chronic Myeloid Leukemia patients of Kashmir
Acceptance Date 30-12-2020
Publication Date Online 20-01-2021
Publication Date 11-10-2021
DOI https://doi.org/10.1111/ijlh.13471
Number of Authors 8
ISSN 1751-5521
EISSN 1751-553X
Journal INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
Listed In Thomson True
Impact Factor 2.7
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 43
Issue Number 5
Web Link https://onlinelibrary.wiley.com/doi/10.1111/ijlh.13471
Web Link Journal https://onlinelibrary.wiley.com/doi/10.1111/ijlh.13471
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
13. Clinical History Matters, Skin Prick Test (SPT) Results are Not the Be-All and End-All for Allergy Diagnosis
Acceptance Date 17-08-2021
Publication Date Online 10-09-2021
Publication Date 10-09-2021
DOI DOI: http://dx.doi.org/10.47746/FMCR.2021.2410
Number of Authors 8
ISSN NA
EISSN NA
Journal Frontiers in Medical Case Reports
Listed In Thomson False
Impact Factor NA
Source of Impact Factor NA
UGC Care List Other
Volume Number 2
Issue Number 0
Web Link https://www.jmedicalcasereports.org/uploads/178/13188_pdf.pdf
Web Link Journal https://www.jmedicalcasereports.org/uploads/178/13188_pdf.pdf
Proof
Author Type Co-Author
Author Serial 5
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
14. Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer
Acceptance Date 20-07-2021
Publication Date Online 02-08-2021
Publication Date 02-08-2021
DOI doi: 10.3390/biomedicines9080938
Number of Authors 12
ISSN NA
EISSN 2227-9059
Journal Biomedicines
Listed In Thomson True
Impact Factor 4.75
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 9
Issue Number 8
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392831/pdf/biomedicines-09-00938.pdf
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392831/pdf/biomedicines-09-00938.pdf
Proof
Author Type Co-Author
Author Serial 8
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
15. Favorable role of IDH1/2 mutations aided with MGMT promoter gene methylation in the outcome of patients with malignant glioma
Acceptance Date 09-11-2020
Publication Date Online 16-03-2021
Publication Date 16-03-2021
DOI doi: 10.2144/fsoa-2020-0057
Number of Authors 14
ISSN 0
EISSN 2056-5623
Journal FUTURE SCIENCE OA
Listed In Thomson True
Impact Factor 2.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 7
Issue Number 3
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849969/#:~:text=Patients%20with%20IDH1%20mutation%20were,with%20a%20chemotherapy%20(temozolomide).
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849969/#:~:text=Patients%20with%20IDH1%20mutation%20were,with%20a%20chemotherapy%20(temozolomide).
Proof
Author Type Co-Author
Author Serial 2
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
16. Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases
Acceptance Date 20-07-2020
Publication Date Online 11-08-2020
Publication Date 05-11-2020
DOI doi: 10.1002/jgm.3260
Number of Authors 12
ISSN 1099-498X
EISSN 1521-2254
Journal The Journal of Gene Medicine
Listed In Thomson True
Impact Factor 4.56
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 22
Issue Number 11
Web Link https://pubmed.ncbi.nlm.nih.gov/32783258/#:~:text=Conclusions%3A%20The%20results%20of%20the,bad%20prognosis%20of%20glioma%20patients.
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/32783258/#:~:text=Conclusions%3A%20The%20results%20of%20the,bad%20prognosis%20of%20glioma%20patients.
Proof
Author Type Co-Author
Author Serial 7
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
17. Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case–Control Study
Acceptance Date 06-05-2020
Publication Date Online 26-05-2020
Publication Date 26-05-2020
DOI doi: 10.1007/s12288-020-01289-6
Number of Authors 7
ISSN 0971-4502
EISSN 0974-0449
Journal Indian Journal of Hematology & Blood Transfusion
Listed In Thomson True
Impact Factor 1.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 37
Issue Number 1
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900282/
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900282/
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
18. Methylenetetrahydrofolate Reductase Gene C677T and A1298C Polymorphic Sequence Variations Influences the Susceptibility to Chronic Myeloid Leukemia in Kashmiri Population
Acceptance Date 21-06-2019
Publication Date Online 24-07-2019
Publication Date 24-07-2019
DOI doi: 10.3389/fonc.2019.00612
Number of Authors 9
ISSN 2234-943X
EISSN 2234-943X
Journal Frontiers in Oncology
Listed In Thomson True
Impact Factor 5.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 9
Issue Number 0
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667548/pdf/fonc-09-00612.pdf
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667548/pdf/fonc-09-00612.pdf
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
19. Influence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide
Acceptance Date 21-12-2018
Publication Date Online 16-02-2019
Publication Date 16-02-2019
DOI https://doi.org/10.1016/j.cancergen.2018.12.003
Number of Authors 8
ISSN 2210-7762
EISSN 1873-4456
Journal Cancer Genetics
Listed In Thomson True
Impact Factor 3.9
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 231-232
Issue Number 1
Web Link https://www.sciencedirect.com/science/article/abs/pii/S2210776218303442#:~:text=The%20heterogeneity%20of%20PML%2DRAR%CE%B1,for%20the%20diagnosis%20of%20APL.
Web Link Journal https://www.sciencedirect.com/science/article/abs/pii/S2210776218303442#:~:text=The%20heterogeneity%20of%20PML%2DRAR%CE%B1,for%20the%20diagnosis%20of%20APL.
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
20. A case series of patients with de novo Philadelphia-positive chronic myelogenous leukemia at tertiary care center SKIMS
Acceptance Date 23-04-2018
Publication Date Online 02-07-2018
Publication Date 02-07-2018
DOI DOI: https://doi.org/10.33883/jms.v19i2.293
Number of Authors 7
ISSN 0972-110X
EISSN 2582-063X
Journal Journal of Medical Sciences
Listed In Thomson False
Impact Factor NA
Source of Impact Factor NA
UGC Care List Other
Volume Number 19
Issue Number 2
Web Link https://jmsskims.org/index.php/jms/article/view/293
Web Link Journal https://jmsskims.org/index.php/jms/article/view/293
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
21. Analysis of ABL kinase domain mutations as a probable cause of imatinib resistance in chronic myeloid leukemia patients of Kashmir
Acceptance Date 14-05-2018
Publication Date Online 17-05-2018
Publication Date 17-05-2018
DOI https://doi.org/10.1016/j.mgene.2018.05.003
Number of Authors 8
ISSN 0
EISSN 2214-5400
Journal Meta Gene
Listed In Thomson False
Impact Factor NA
Source of Impact Factor NA
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 17
Issue Number 0
Web Link https://pdf.sciencedirectassets.com/287971/1-s2.0-S2214540018X00036/1-s2.0-S2214540018300537/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjENX%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIGvy8WWre1SiG8wshn9o3KhE9CmPnxLYzYhPiDFbdi%2FeAiEAuZFJffRz0DL2%2FpapbwMDRcfPngCEvh9bKeyibJYNyGsqsgUIXRAFGgwwNTkwMDM1NDY4NjUiDHKtwBFRBCZgd%2FIjoCqPBdFwAifnIrw96osWXpPraKefIBLAgzNy9m%2B%2BNnGUW9SecrhYr%2F13eSfdUPZLsv9ieM%2BpxnN4Jc5yfQE3qIsyktcBiFeeU30jHyJP8fI0JWgPnTjDKErL86vNV2rmybloi0lbjG2lwU5QWkymJLrHbrZ
Web Link Journal https://pdf.sciencedirectassets.com/287971/1-s2.0-S2214540018X00036/1-s2.0-S2214540018300537/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjENX%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIGvy8WWre1SiG8wshn9o3KhE9CmPnxLYzYhPiDFbdi%2FeAiEAuZFJffRz0DL2%2FpapbwMDRcfPngCEvh9bKeyibJYNyGsqsgUIXRAFGgwwNTkwMDM1NDY4NjUiDHKtwBFRBCZgd%2FIjoCqPBdFwAifnIrw96osWXpPraKefIBLAgzNy9m%2B%2BNnGUW9SecrhYr%2F13eSfdUPZLsv9ieM%2BpxnN4Jc5yfQE3qIsyktcBiFeeU30jHyJP8fI0JWgPnTjDKErL86vNV2rmybloi0lbjG2lwU5QWkymJLrHbrZ
Proof
Author Type Co-Author
Author Serial 6
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
22. Pathogenetic implication of fusion genes in acute promyelocytic leukemia and their diagnostic utility
Acceptance Date 17-01-2018
Publication Date Online 26-04-2018
Publication Date 26-04-2018
DOI doi: 10.1111/cge.13372.
Number of Authors 4
ISSN 0009-9163
EISSN 1399-0004
Journal Clinical Genetics
Listed In Thomson True
Impact Factor 4.9
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 95
Issue Number 1
Web Link https://pubmed.ncbi.nlm.nih.gov/29700805/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/29700805/
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
23. p15Ink4b Loss of Expression by Promoter Hypermethylation Adds to Leukemogenesis and Confers a Poor Prognosis in Acute Promyelocytic Leukemia Patients
Acceptance Date 21-10-2016
Publication Date Online 05-12-2016
Publication Date 05-12-2016
DOI https://doi.org/10.4143/crt.2016.108
Number of Authors 7
ISSN 1598-2998
EISSN 2005-9256
Journal Cancer Research & Treatment
Listed In Thomson True
Impact Factor 5.3
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 49
Issue Number 3
Web Link https://pubmed.ncbi.nlm.nih.gov/28052659/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/28052659/
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
24. PHA-Induced Peripheral Blood Cytogenetics and Molecular Analysis: a Valid Diagnostic and Follow-up Modality for Acute Promyelocytic Leukemia Patients Treated with ATRA and/or Arsenic Tri-oxide
Acceptance Date 04-03-2016
Publication Date Online 20-04-2016
Publication Date 20-04-2016
DOI doi: 10.7314/apjcp.2016.17.4.1999.
Number of Authors 8
ISSN 1513-7368
EISSN 2476-762X
Journal Asian Pacific Journal of Cancer Prevention
Listed In Thomson True
Impact Factor 2.6
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 17
Issue Number 4
Web Link https://pubmed.ncbi.nlm.nih.gov/27221887/#:~:text=Arsenic%20Tri%2Doxide-,PHA%2DInduced%20Peripheral%20Blood%20Cytogenetics%20and%20Molecular%20Analysis%3A%20a%20Valid,and%2For%20Arsenic%20Tri%2Doxide
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/27221887/#:~:text=Arsenic%20Tri%2Doxide-,PHA%2DInduced%20Peripheral%20Blood%20Cytogenetics%20and%20Molecular%20Analysis%3A%20a%20Valid,and%2For%20Arsenic%20Tri%2Doxide
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
25. Phytohemagglutinin-Induced Peripheral Blood Cytogenetics: A Valid Means for Diagnosis and Imatinib Therapy Monitoring of Chronic Phase Chronic Myeloid Leukemia Patients
Acceptance Date 17-07-2015
Publication Date Online 21-07-2015
Publication Date 21-07-2015
DOI DOI: 10.4172/1948-5956.1000356
Number of Authors 8
ISSN 1948-5956
EISSN 0
Journal rnal ofJournal ofJournal ofJournal of Cancer Science & Science & Science & Science & Therapy
Listed In Thomson False
Impact Factor 3.5
Source of Impact Factor NA
UGC Care List UGC-CARE List Group I
Volume Number 7
Issue Number 8
Web Link https://www.hilarispublisher.com/open-access/phytohemagglutinininduced-peripheral-blood-cytogenetics-a-valid-means-for-diagnosis-and-imatinib-therapy-monitoring-of-chronic-phase-chronic-myeloid-leukemia-patients-1948-5956-1000356.pdf
Web Link Journal https://www.hilarispublisher.com/open-access/phytohemagglutinininduced-peripheral-blood-cytogenetics-a-valid-means-for-diagnosis-and-imatinib-therapy-monitoring-of-chronic-phase-chronic-myeloid-leukemia-patients-1948-5956-1000356.pdf
Proof
Author Type Co-Author
Author Serial 2
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
26. RAD51 G135C gene polymorphism and risk of colorectal cancer in Kashmir
Acceptance Date 18-03-2014
Publication Date Online 01-07-2014
Publication Date 01-07-2014
DOI doi: 10.1097/CEJ.0000000000000049.
Number of Authors 6
ISSN 0959-8278
EISSN 1473-5709
Journal EUROPEAN JOURNAL OF CANCER PREVENTION
Listed In Thomson True
Impact Factor 2.8
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 23
Issue Number 4
Web Link https://pubmed.ncbi.nlm.nih.gov/24871558/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/24871558/
Proof
Author Type Co-Author
Author Serial 2
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
27. Prevalence of various chromosomal disorders diagnosed in a selected population suspected of having genetic diseases from different regions of the valley of Kashmir, North India
Acceptance Date 23-11-2013
Publication Date Online 02-12-2013
Publication Date 02-12-2013
DOI https://doi.org/10.1007/s13237-013-0098-0
Number of Authors 11
ISSN 0029-568X
EISSN 0976-7975
Journal The Nucleus
Listed In Thomson True
Impact Factor 0.7
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 56
Issue Number 0
Web Link https://link.springer.com/article/10.1007/s13237-013-0098-0#article-info
Web Link Journal https://link.springer.com/article/10.1007/s13237-013-0098-0#article-info
Proof
Author Type Co-Author
Author Serial 9
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
28. A case of primary amenorrhea with 46+XY genotype from Kashmir Valley
Acceptance Date 03-07-2013
Publication Date Online 19-09-2013
Publication Date 19-09-2013
DOI DOI: 10.4103/0971-6866.120816
Number of Authors 3
ISSN 09716866
EISSN 1998362X
Journal Indian Journal of Human Genetics
Listed In Thomson True
Impact Factor 0.5
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 19
Issue Number 3
Web Link https://pubmed.ncbi.nlm.nih.gov/24339555/
Web Link Journal https://pubmed.ncbi.nlm.nih.gov/24339555/
Proof
Author Type First Author
Author Serial 1
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
29. Helicobacter pylori in colorectal neoplasms of Kashmiri patients: What is the prevalence?
Acceptance Date 01-01-2012
Publication Date Online 01-01-2012
Publication Date 13-03-2012
DOI NA
Number of Authors 6
ISSN 2278-1668
EISSN 2278-0513
Journal CLINICAL CANCER INVESTIGATION JOURNAL
Listed In Thomson False
Impact Factor NA
Source of Impact Factor NA
UGC Care List Other
Volume Number 1
Issue Number 1
Web Link https://d1wqtxts1xzle7.cloudfront.net/69829279/Helicobacter_pylori_in_colorectal_neopla20210917-13411-jdldxx.pdf?1631933148=&response-content-disposition=inline%3B+filename%3DHelicobacter_pylori_in_colorectal_neopla.pdf&Expires=1738185145&Signature=DMD7adQrocJAjCRwStA191s8FRPIVXADIyPy2hGcB6Xcs3r3nQPJ11Qc8RW5KAd8GhgkvciaTr1zr2wURUhFLnZR1qqGG3IknTAaUYP9youRiB8GZE67qAdxzgLXKC6HodZJx2gf6kas7yDgayeDx8fyUCJPB9Y9Btv4xQT1-6k2vi0n7vLF3cscsZv~El-sB7Ia1~a-zfVbSqgBpvmkKKWxy1sKz5HY5aaIukAfX64q26D6wHLvMxPbcoi
Web Link Journal https://d1wqtxts1xzle7.cloudfront.net/69829279/Helicobacter_pylori_in_colorectal_neopla20210917-13411-jdldxx.pdf?1631933148=&response-content-disposition=inline%3B+filename%3DHelicobacter_pylori_in_colorectal_neopla.pdf&Expires=1738185145&Signature=DMD7adQrocJAjCRwStA191s8FRPIVXADIyPy2hGcB6Xcs3r3nQPJ11Qc8RW5KAd8GhgkvciaTr1zr2wURUhFLnZR1qqGG3IknTAaUYP9youRiB8GZE67qAdxzgLXKC6HodZJx2gf6kas7yDgayeDx8fyUCJPB9Y9Btv4xQT1-6k2vi0n7vLF3cscsZv~El-sB7Ia1~a-zfVbSqgBpvmkKKWxy1sKz5HY5aaIukAfX64q26D6wHLvMxPbcoi
Proof
Author Type Co-Author
Author Serial 5
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences
30. Role of CYP2E1 genotypes in susceptibility to colorectal cancer in the Kashmiri population
Acceptance Date 22-03-2011
Publication Date Online 01-10-2011
Publication Date 01-10-2011
DOI doi: 10.1186/1479-7364-5-6-530.
Number of Authors 6
ISSN 0
EISSN 1479-7364
Journal Hum Genomics
Listed In Thomson True
Impact Factor 1.5
Source of Impact Factor Thomson Reuters
UGC Care List UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number 5
Issue Number 6
Web Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525247/pdf/1479-7364-5-6-530.pdf
Web Link Journal https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525247/pdf/1479-7364-5-6-530.pdf
Proof
Author Type Co-Author
Author Serial 5
Affiliating Institute Sher-i-Kashmir Institute of Medical Sciences

Overview

5

Total

LevelTotal
International (Abroad)1
International (Within Country)2
National1
University1

Conference / Seminar Details

ParticipationPaper TitleTitle of Conference/SeminarISBNFromTo
Paper Presented / PublishedEffectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From KashmirAsia Pacific Association of Allergy, Asthma and Clinical Immunology 15-10-202117-10-2021
Paper Presented / PublishedHypermethylation of RARA P2 can be the driving force for the virulence of bcr-3 PML-RARα fusion gene transcript in Acute Promyelocytic Leukemia.2019 Asian Advanced Course in Basic and Clinical Immunology 26-03-201929-03-2019
Paper Presented / PublishedInfluence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide2019 Asian Advanced Course in Basic and Clinical Immunology 26-03-201929-03-2019
Paper Presented / Publishedp15Ink4b Loss of Expression by Promoter Hypermethylation Adds to Leukemogenesis and Confers a Poor Prognosis in Acute Promyelocytic Leukemia Patients2nd JK Medical Science Congress 10-05-201712-05-2017
Paper Presented / PublishedGenetic Variations in Acute Promyelocytic LeukemiaPostgraduate Research Presentation Programme (PGRP-2016) 18-03-201619-03-2016

Overview

1

Total Books

2

Book Chapters

PublicationTypeParticipationTotal
BookAuthored1
ChapterAuthored1
ChapterEdited1

Books / Chapters Details

Title of Book :

Breast Cancer: From Bench to Personalized Medicine

Chapter ( Authored ) | Publisher : Springer Nature |
Title of Chapter : Implications of BRCA1, BRCA2 Gene in Overall Development and Prognosis of Breast Cancer
ParticipationAffiliating Institute
Main AuthorSher-i-Kashmir Institute of Medical Sciences
Title of Book :

Genetic Polymorphisms - New Insights

Chapter ( Edited ) | Publisher : Intech Open |
Title of Chapter : Cytokine Gene Polymorphism and Cancer Risk: A Promising Tool for Individual Susceptibility and Prognostic Implications
ParticipationAffiliating Institute
Main AuthorSher-i-Kashmir Institute of Medical Sciences
Title of Book :

Genetic Variations in Acute Promyelocytic Leukemia patients

Book ( Authored ) | Publisher : LAP LAMBERT Academic Publishing |
Title of Chapter :
ParticipationAffiliating Institute
Main AuthorSher-i-Kashmir Institute of Medical Sciences

Overview

0

Total

Projects Details

Overview

2

NameParticipationTotal
Program Participant1
Syllabus Upgradation Workshop/TrainingParticipant1
DurationTotal
Less Than One Week1
Two Week1
Year WiseTotal
20141
20191

FDP / Workshop Details

NameTitleAgencyFunding AgencyDurationModeFromTo
Syllabus Upgradation Workshop/TrainingAdvanced Course in Basic and Clinical ImmunologyFederation of Clinical Immunology Societies (FOCIS)NALess Than One WeekOffline26-03-201929-03-2019
Program Short term training in the department of Hematology at All India Institute of Medical Sciences (AIIMS), New DelhiAll India Institute of Medical Sciences (AIIMS), New Delhi NATwo WeekOffline28-04-201409-05-2014

Overview

0

Total

Research Guidance Details

Overview

LevelTotal
State2

LevelTypeAwardNameAwardingAgencyYear
StateAwardBest Research Paper AwardSher-i-Kashmir Institute of Medical Sciences2017
StateAwardBest Ph.D student AwardSher-i-Kashmir Institute of Medical Sciences2017